Top Markets
Coin of the day
TMS Co., Ltd. TMS Co., Ltd.

TMS Co., Ltd.

4891
Peringkat dalam Saham #27368
Established in 2005 and headquartered in Fuchu, Japan, TMS Co., Ltd. focuses on... Established in 2005 and headquartered in Fuchu, Japan, TMS Co., Ltd. focuses on the research, development, manufacturing, and commercialization of pharmaceuticals, quasi-drugs, drug substances, medical devices, and various medical commodities. The company's pipeline includes TMS-007, an SMTP congener demonstrating both prothrombolytic and anti-inflammatory/antioxidative activities, which has advanced through Phase 2a clinical trials for the treatment of acute ischemic stroke. Additionally, TMS-008, another SMTP congener with anti-inflammatory/antioxidative properties, is undergoing nonclinical development for addressing inflammatory complications like acute kidney injury and cancer cachexia. A third product candidate, TMS-009, is currently in preclinical development. TMS Co., Ltd. collaborates with Hokkaido University and Kanazawa University to assess the potential of its drug candidates, has a joint research agreement with Teikyo University to identify renal function biomarkers, and maintains a strategic alliance with Ji Xing Pharmaceuticals Limited.
Harga Saham
$0.73072946
Kapitalisasi Pasar
$33.30M
Perubahan (1 hari)
0.00%
Perubahan (1 tahun)
-31.85%
Negara
JP
Perdagangan TMS Co., Ltd. (4891)

Kategori

Riwayat hasil dividen untuk TMS Co., Ltd. (4891)
Hasil dividen (TTM) dari TMS Co., Ltd. (simbol saham: 4891) per 2026: 0
Rata-rata hasil dividen selama 5 tahun terakhir: 0.00%
Riwayat hasil dividen untuk TMS Co., Ltd. (4891) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Hasil dividen (TTM) untuk perusahaan serupa atau pesaing
Perusahaan Hasil Dividen Negara
0.00%
US
0.00%
US
0.00%
NL
3.12%
AU
0.00%
CH